Drastic Reduction in Time to Controlled Viral Load in People With Human Immunodeficiency Virus in France, 2009-2019: A Longitudinal Cohort Study

被引:2
作者
Cuzin, Lise [1 ,2 ,6 ]
Morisot, Adeline [3 ]
Allavena, Clotilde [4 ]
Lert, France
Pugliese, Pascal [3 ,5 ,7 ]
机构
[1] Toulouse Univ, CERPOP, INSERM, UPS,UMR1295, Toulouse, France
[2] Martinique Univ Hosp, Infect & Trop Dis, Fort De France, Martinique Fwi, France
[3] Cote Azur Univ, Archet Hosp, Corevih Paca Est, Nice, France
[4] Nantes Univ Hosp, Infect & Trop Dis Dept, INSERM, CIC1413, Nantes, France
[5] Paris Sans Sida Program, Paris, France
[6] Univ Hosp Martinique, Infect & Trop Dis, F-97200 Fort De France, Martinique, France
[7] Cote Azur Univ, Archet Hosp, Corevih Paca Est, 151 Rue St Antoine, F-06000 Nice, France
关键词
HIV; linkage to care; ART initiation; transition; cascade of care; HIV CARE CONTINUUM; ANTIRETROVIRAL THERAPY; POPULATION; INFECTION; CASCADE; END;
D O I
10.1093/cid/ciad530
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Aspirational targets to end AIDS by 2030 include having 95% of people with human immunodeficiency virus (HIV; PWH) diagnosed, 95% treated, and 95% with controlled viral load (VL). Our objective was to describe, using a large French prospective cohort, the median transition times through the cascade of care between 2009 and 2019.Methods We analyzed patients whose first HIV diagnosis was made between 1 January 2009 and 31 December 2019. Using the Kaplan-Meier method, we estimated the time to linkage to care (from HIV diagnosis to first biological assessment), to treatment (date of first antiretroviral therapy [ART] prescription), and to controlled VL (first value <200 copies/mL). Analyses were disaggregated by time periods and patients' characteristics. Censoring date was 31 December 2021.Results Among the 16 864 patients linked to care since 2009, the median [Q1; Q3] time from HIV diagnosis to controlled VL decreased from 254 [127-745] to 73 [48-132] days in 2009-2011 and 2018-2019, respectively. Transition times from linkage to care to first ART decreased from 67 [17; 414] in 2009-2011 to 13 [5; 26] days in 2018-2019, and from ART to controlled VL from 83 [35; 130] in 2009-2011 to 38 [28; 90] days in 2018-2019. Differences were observed depending on patients' characteristics.Conclusions We describe drastic reductions in transition time through the cascade of care, allowing reduction in the transmission period following each new infection. Delayed diagnosis remains the main obstacle to ending AIDS in the next decade.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 25 条
  • [1] Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
    Bavinton, Benjamin R.
    Pinto, Angie N.
    Phanuphak, Nittaya
    Grinsztejn, Beatriz
    Prestage, Garrett P.
    Zablotska-Manos, Iryna B.
    Jin, Fengyi
    Fairley, Christopher K.
    Moore, Richard
    Roth, Norman
    Bloch, Mark
    Pell, Catherine
    McNulty, Anna M.
    Baker, David
    Hoy, Jennifer
    Tee, Ban Kiem
    Templeton, David J.
    Cooper, David A.
    Emery, Sean
    Kelleher, Anthony
    Grulich, Andrew E.
    [J]. LANCET HIV, 2018, 5 (08): : E438 - E447
  • [2] The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review
    Broyles, Laura N.
    Luo, Robert
    Boeras, Debi
    Vojnov, Lara
    [J]. LANCET, 2023, 402 (10400) : 464 - 471
  • [3] HIV treatment-as-prevention and its effect on incidence of HIV among cisgender gay, bisexual, and other men who have sex with men in Australia: a 10-year longitudinal cohort study
    Callander, Denton
    McManus, Hamish
    Gray, Richard T.
    Grulich, Andrew E.
    Carr, Andrew
    Hoy, Jennifer
    Donovan, Basil
    Fairley, Christopher K.
    Holt, Martin
    Templeton, David J.
    Liaw, Siaw-Teng
    McMahon, James H.
    Asselin, Jason
    Petoumenos, Kathy
    Hellard, Margaret
    Pedrana, Alisa
    Elliott, Julian
    Keen, Phillip
    Costello, Jane
    Keane, Richard
    Kaldor, John
    Stoove, Mark
    Guy, Rebecca
    [J]. LANCET HIV, 2023, 10 (06): : E385 - E393
  • [4] Champenois Karen, 2020, Bulletin Epidemiologique Hebdomadaire, P657
  • [5] CO4-FHDH A, 2019, GRAPH RAPP RET INF C
  • [6] Antiretroviral Therapy to Prevent HIV Acquisition: Limits of Estimation From a Population Cohort
    Cohen, Myron
    Eshleman, Susan
    McCauley, Marybeth
    Chen, Ying
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 63 (12) : 1679 - +
  • [7] Defining linkage to care following human immunodeficiency virus (HIV) diagnosis for public health monitoring in Europe
    Croxford, Sara
    Raben, Dorthe
    Jakobsen, Stine F.
    Burns, Fiona
    Copas, Andrew
    Brown, Alison E.
    Delpech, Valerie C.
    [J]. EUROSURVEILLANCE, 2018, 23 (48): : 21 - 25
  • [8] No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study
    Cuzin, Lise
    Allavena, Clotilde
    Cotte, Laurent
    Delpierre, Cyrille
    Huleux, Thomas
    Palich, Romain
    Delobel, Pierre
    Raffi, Francois
    Cabie, Andre
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (06) : 1573 - 1579
  • [9] Can the "Seek, Test, Treat, and Retain" Strategy be Effective in France?
    Cuzin, Lise
    Allavena, Clotilde
    Pugliese, Pascal
    Rey, David
    Hoen, Bruno
    Poizot-Martin, Isabelle
    Cabie, Andre
    Yazdanpanah, Yazdan
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (04) : E119 - E121
  • [10] Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013
    Desgrees-du-Lou, A.
    Pannetier, J.
    Ravalihasy, A.
    Gosselin, A.
    Supervie, V.
    Panjo, H.
    Bajos, N.
    Lert, F.
    Lydie, N.
    Dray-Spira, R.
    [J]. EUROSURVEILLANCE, 2015, 20 (46): : 31 - 38